|
|
|
|---|---|
|
|
2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)etanol L-tartaric asid; 2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-etanol (2R,3R)-2,3-dihydroxybutandioate;Ticagrelor InterMediate; 2-((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)etanòl L-tartaric asid; 2-[(3aR,4S,6R,6aS)-6-aminotetrahydro-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy]etanol (2R,3R)-2,3-dihydroxybutandioate; 2-((((3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl)oxy)etanòl (2R,3S,4R,5R)-2,3,4,5-tetrahydroxyhexanedioate; 2-[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxyethanol L-tartrat |
|
|
|
|
|
|
|
|
|
|
|
|
| Metòd pwodiksyon | ![]() |
| Itilizasyon | - Famasetik Entèmedyè: précurseur kle pou sentèz deTikagrelor, yon medikaman antiplakèt yo itilize pou anpeche boul nan san nan pasyan ki gen sendwòm kardyovaskulèr egi (ACS) oswa enfaktis myokad (MI). - Itilizasyon laboratwa: Travay nan sentèz òganik pou devlopman dwòg ak rechèch chimi medsin. - Pwodiksyon API: Etap kritik nan pwosesis fabrikasyon Ticagrelor, asire bon aktivite famasi nan dwòg final la. |
Baj popilè: cas 376608-65-0 2-((3ar,4s,6r,6as)-6-amino-2,2-dimethyltetrahydro-3ah-cyclopenta[d][1,3]dioxol-4-yloxy)etanòl l-tataric asid, Lachin, manifaktirè, founisè, faktori, koutim, wholesale
